Literature DB >> 26018983

Fundamental reaction pathway and free energy profile of proteasome inhibition by syringolin A (SylA).

Donghui Wei1, Mingsheng Tang, Chang-Guo Zhan.   

Abstract

In this study, molecular dynamics (MD) simulations and first-principles quantum mechanical/molecular mechanical free energy (QM/MM-FE) calculations have been performed to uncover the fundamental reaction pathway of proteasome with a representative inhibitor syringolin A (SylA). The calculated results reveal that the reaction process consists of three steps. The first step is a proton transfer process, activating Thr1-O(γ) directly by Thr1-N(z) to form a zwitterionic intermediate. The next step is a nucleophilic attack on the olefin carbon of SylA by the negatively charged Thr1-O(γ) atom. The last step is a proton transfer from Thr1-N(z) to another olefin carbon of SylA to complete the inhibition reaction process. The calculated free energy profile demonstrates that the second step should be the rate-determining step and has the highest free energy barrier of 24.6 kcal mol(-1), which is reasonably close to the activation free energy (∼22.4-23.0 kcal mol(-1)) derived from the available experimental kinetic data. In addition, our computational results indicate that no water molecule can assist the rate-determining step, since the second step is not involved in a proton transfer process. The obtained mechanistic insights should be valuable for understanding the inhibition process of proteasome by SylA and structurally related inhibitors at a molecular level, and thus provide a solid mechanistic base and valuable clues for future rational design of novel, more potent inhibitors of proteasome.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26018983      PMCID: PMC4472459          DOI: 10.1039/c5ob00737b

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  65 in total

Review 1.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Not just research tools--proteasome inhibitors offer therapeutic promise.

Authors:  Alfred L Goldberg; Kenneth Rock
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

3.  Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor.

Authors:  M Groll; Y Koguchi; R Huber; J Kohno
Journal:  J Mol Biol       Date:  2001-08-17       Impact factor: 5.469

4.  Synthesis, in vitro and in vivo biological evaluation, and comprehensive understanding of structure-activity relationships of dipeptidyl boronic acid proteasome inhibitors constructed from β-amino acids.

Authors:  Yongqiang Zhu; Gang Wu; Xinrong Zhu; Yuheng Ma; Xin Zhao; Yuejie Li; Yunxia Yuan; Jie Yang; Sen Yu; Feng Shao; Meng Lei
Journal:  J Med Chem       Date:  2010-11-15       Impact factor: 7.446

5.  Fundamental reaction pathway for peptide metabolism by proteasome: insights from first-principles quantum mechanical/molecular mechanical free energy calculations.

Authors:  Donghui Wei; Lei Fang; Mingsheng Tang; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2013-10-10       Impact factor: 2.991

6.  Alpha,beta-unsaturated N-acylpyrrole peptidyl derivatives: new proteasome inhibitors.

Authors:  Anna Baldisserotto; Valeria Ferretti; Federica Destro; Christian Franceschini; Mauro Marastoni; Riccardo Gavioli; Roberto Tomatis
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

7.  Molecular basis of the selectivity of the immunoproteasome catalytic subunit LMP2-specific inhibitor revealed by molecular modeling and dynamics simulations.

Authors:  Beilei Lei; Mohamed Diwan M Abdul Hameed; Adel Hamza; Marie Wehenkel; Jennifer L Muzyka; Xiao-Jun Yao; Kyung-Bo Kim; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2010-09-30       Impact factor: 2.991

8.  Crystal structures of Salinosporamide A (NPI-0052) and B (NPI-0047) in complex with the 20S proteasome reveal important consequences of beta-lactone ring opening and a mechanism for irreversible binding.

Authors:  Michael Groll; Robert Huber; Barbara C M Potts
Journal:  J Am Chem Soc       Date:  2006-04-19       Impact factor: 15.419

9.  Reaction Pathway and Free Energy Profile for Cocaine Hydrolase-Catalyzed Hydrolysis of (-)-Cocaine.

Authors:  Junjun Liu; Chang-Guo Zhan
Journal:  J Chem Theory Comput       Date:  2012-03-06       Impact factor: 6.006

10.  Function-oriented biosynthesis of beta-lactone proteasome inhibitors in Salinispora tropica.

Authors:  Markus Nett; Tobias A M Gulder; Andrew J Kale; Chambers C Hughes; Bradley S Moore
Journal:  J Med Chem       Date:  2009-10-08       Impact factor: 7.446

View more
  5 in total

1.  Reaction Pathway for Cocaine Hydrolase-Catalyzed Hydrolysis of (+)-Cocaine.

Authors:  Yuan Yao; Junjun Liu; Fang Zheng; Chang-Guo Zhan
Journal:  Theor Chem Acc       Date:  2015-12-28       Impact factor: 1.702

2.  Catalytic Mechanisms for Cofactor-Free Oxidase-Catalyzed Reactions: Reaction Pathways of Uricase-Catalyzed Oxidation and Hydration of Uric Acid.

Authors:  Donghui Wei; Xiaoqin Huang; Yan Qiao; Jingjing Rao; Lu Wang; Fei Liao; Chang-Guo Zhan
Journal:  ACS Catal       Date:  2017-06-15       Impact factor: 13.084

Review 3.  Computational Approaches for the Discovery of Human Proteasome Inhibitors: An Overview.

Authors:  Romina A Guedes; Patrícia Serra; Jorge A R Salvador; Rita C Guedes
Journal:  Molecules       Date:  2016-07-16       Impact factor: 4.411

4.  Insight into Inhibitor Binding in the Eukaryotic Proteasome: Computations of the 20S CP.

Authors:  Milan Hodošček; Nadia Elghobashi-Meinhardt
Journal:  Int J Mol Sci       Date:  2018-12-03       Impact factor: 5.923

5.  Evaluation of the Antifungal Activities of Photorhabdus akhurstii and Its Secondary Metabolites against Phytopathogenic Colletotrichum gloeosporioides.

Authors:  Po-Wen Tu; Jie-Siang Chiu; Chih Lin; Chih-Cheng Chien; Feng-Chia Hsieh; Ming-Che Shih; Yu-Liang Yang
Journal:  J Fungi (Basel)       Date:  2022-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.